금융 뉴스 허브
실시간 글로벌 금융 시장 뉴스 · 분석 · 인사이트
BREAKING주요 뉴스
Apple to fight $500mn patent bill at UK Supreme Court
Battle over licensing of mobile connection protocols could shape global rates for other technologies...
Mines will hold back Strait of Hormuz shipping for months, CEO warns
NYK’s Takaya Soga says safe routes are ‘extremely limited’, restricting traffic to half prewar level...
Capex boom threatens to crowd out buybacks, key equity demand driver
Investing.com -- A surge in artificial intelligence-related capital spending is unlikely to undermin...
Watch the SpaceX Genesis Line -- chartists
Air Canada reaches tentative labor agreement with more than 11,000 workers
Quant snapshot: RF Industries, Vince Holding lead top-rated names as Dave & Buster's, Domo lag
McDonald’s looks beyond Coca-Cola as it chases specialty drink boom
Dow Jones Futures: No Iran Deal Yet; Five Stocks In Buy Areas, SpaceX's Next Test
President Trump posted Saturday than an Iran deal would "get signed" Sunday. The stock market still must do this. What's next for SpaceX?
Notable healthcare headlines for the week: GSK, Parabilis Medicines, and Novo Nordisk in focus
SpaceX shows investors still want moonshots. The Fed may test that theory this week.
Higher interest rates could make the AI growth story that’s been powering the bull market harder to justify.
U.S., Iran edge toward deal as fighting continues and hardliners push back
Why IonQ Stock Ended This Week in the Green Despite Early Sell-Offs
IonQ bounced back from being down double digits and ended the week in positive territory.
VGLT vs. TLT: Which Treasury Bond ETF Is the Better Buy?
Expense-conscious investors may find one fund's risk profile and historical growth especially compelling compared to its larger rival.
Dave Ramsey says most millionaires just copied the guy in the next cubicle — not debating the perfect portfolio
The personal finance personality shared his thoughts on what he sees as one of the biggest mistakes would-be investors make.
AI gold rush powers $100B fundraising frenzy despite rising risks: FT